02161.HK
JBM (Healthcare) Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 1.89
+1.61%Year over year
Reported trailing growth
- Revenue
- +38.3%
- EBITDA
- +86.4%
- EBIT
- +112.6%
- EPS
- +131.8%
- Free cash flow
- +3.1%
- Operating cash flow
- +13.7%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +17.1%
- EBITDA
- +39.7%
- EBIT
- +55.3%
- Net income
- +52.1%
- EPS
- +57.5%
- Free cash flow
- -4.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026